| Previous Close | 0.2600 |
| Open | 0.2600 |
| Bid | 0.2500 x 0 |
| Ask | 0.2550 x 0 |
| Day's Range | 0.2500 - 0.2600 |
| 52 Week Range | 0.1100 - 0.8600 |
| Volume | 1,821,558 |
| Avg. Volume | 1,357,885 |
| Market Cap | 129.928M |
| Beta (3Y Monthly) | 1.60 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0550 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (PU31.F) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to announce the Company’s wholly owned subsidiary, Canutra Naturals Ltd. (“Canutra”), has been awarded a cannabis research licence (the “Research License”) by Health Canada under the Cannabis Regulations Act. The Research License permits Canutra to pursue the development of proprietary cannabis genetics and phenotypes at its flagship 76-acre campus in Kent County, New Brunswick.
AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (PU31.F) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to announce the Company’s wholly owned subsidiary, Canutra Naturals Ltd. (“Canutra”), has been awarded a cannabis research licence (the “Research License”) by Health Canada under the Cannabis Regulations Act. The Research License permits Canutra to pursue the development of proprietary cannabis genetics and phenotypes at its flagship 76-acre campus in Kent County, New Brunswick.
AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased announce that the Company’s 51,500 square foot GMP edibles manufacturing facility (the “Facility”) in Winnipeg, Manitoba has received all required architecture and ancillary construction permits and continues to adhere to its projected Q4 2019 completion date for applicable Facility upgrades, including architectural, mechanical, electrical, as well as security retrofits, per Health Canada regulations.
AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased announce that the Company’s 51,500 square foot GMP edibles manufacturing facility (the “Facility”) in Winnipeg, Manitoba has received all required architecture and ancillary construction permits and continues to adhere to its projected Q4 2019 completion date for applicable Facility upgrades, including architectural, mechanical, electrical, as well as security retrofits, per Health Canada regulations.
Evidence Package submission is the final measure required in order to demonstrate and confirm to Health Canada that the Delta Greenhouse Complex is fully built, operationally ready and in compliance with the Cannabis Act and Cannabis Regulations, prior to being issued its standard cultivation licence. The Company’s Phase 1 retrofit of its flagship Delta Greenhouse Complex is comprised of approximately 431,000 square feet of cultivation/processing expanse, including over 130,000 square feet of net flower canopy and is estimated to produce 15,000,000 million grams of premium cannabis annually.
Evidence Package submission is the final measure required in order to demonstrate and confirm to Health Canada that the Delta Greenhouse Complex is fully built, operationally ready and in compliance with the Cannabis Act and Cannabis Regulations, prior to being issued its standard cultivation licence. The Company’s Phase 1 retrofit of its flagship Delta Greenhouse Complex is comprised of approximately 431,000 square feet of cultivation/processing expanse, including over 130,000 square feet of net flower canopy and is estimated to produce 15,000,000 million grams of premium cannabis annually.
VANCOUVER, British Columbia, Aug. 27, 2019 -- AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), a growth.
AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (PU31.F) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to announce that the Company has entered into a definitive agreement to acquire 50 per-cent of the issued and outstanding shares of Eurasia Infused Cosmetics Inc. (“Eurasia Infused”). AgraFlora and Eurasia will collaborate to integrate the Company’s vertically integrated, farm-to-face CBD processing, manufacturing and distribution model into the Asia Pacific region. Eurasia Infused, by way of a commercial concession with Hong Kong domiciled CBD Group Asia Limited (“CBD Group Asia”) controls a distribution agreement for CBD and hemp-derived beauty and wellness products for the territories of People's Republic of China (“China”) and Hong Kong Special Administrative Region.
AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (PU31.F) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to announce that the Company has entered into a definitive agreement to acquire 50 per-cent of the issued and outstanding shares of Eurasia Infused Cosmetics Inc. (“Eurasia Infused”). AgraFlora and Eurasia will collaborate to integrate the Company’s vertically integrated, farm-to-face CBD processing, manufacturing and distribution model into the Asia Pacific region. Eurasia Infused, by way of a commercial concession with Hong Kong domiciled CBD Group Asia Limited (“CBD Group Asia”) controls a distribution agreement for CBD and hemp-derived beauty and wellness products for the territories of People's Republic of China (“China”) and Hong Kong Special Administrative Region.
AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (PU31.F) (OTCPK: AGFAF), announces that further to its news release of August 9, 2019 announcing its intention to make an offer (the “Offer”) directly to the shareholders of Eviana Health Corporation (“Eviana”) to purchase all of the issued and outstanding common shares (the “Eviana Shares”), it has received confirmations of support from Eviana shareholders that exceeds the statutory minimum condition of 50% of the outstanding Eviana Shares. Full details of the Offer are expected to be set out in the formal Offer and take-over bid circular which is expected to be mailed to Eviana shareholders, a copy of which is expected to be available at www.sedar.com under Eviana’s profile. AgraFlora expects to formally commence the Offer and mail the Offer and take-over bid circular to Eviana shareholders over the coming weeks.
AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (PU31.F) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, announces that it has completed debt settlements whereby the Company issued a total of 319,551 common shares at deemed values of $0.34 and $0.36 per common share to certain creditors for past consulting and other services provided to Canutra Naturals Ltd., a wholly-owned subsidiary of the Company, totaling approximately $111,805. AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry.
The Offer will provide holders of Eviana Shares with 1.694915 AgraFlora shares (the “AgraFlora Shares”) for each Eviana share based on the offer price of $0.50 per Eviana share and the closing price of AgraFlora shares of $0.295 on August 9, 2019.
AgraFlora Organics International Inc. ("AgraFlora" or the "Company") (CSE: AGRA) (PU31.F) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, announced that effective August 8th, 2019 AgraFlora will trade under the OTC symbol AGFAF. AgraFlora is also listed on the Frankfurt Stock Exchange under the symbol PU31 and on the Canadian Securities Exchange under the symbol AGRA. The Company's trilisting contributes to a genuine global presence and affords investors pre-eminent access to trading liquidity.
AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (PU31.F) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to announced the Company has commenced discussions, as well as entered into a non-binding Cannabidiol (“CBD”) Commercialization and Consulting Letter of Intent (“LOI”), dated July 31st, 2019, with one of Canada’s largest food retailers (the “Canadian Food Retailer”). The Canadian Food Retailer boasts brick and mortar stores from coast to coast, which operate under a variety of renowned retail banners. Under the terms of the non-binding LOI, AgraFlora and the Canadian Food Retailer will pursue a Supply and Consulting Agreement (the “Supply Agreement”), whereby AgraFlora will supply the Canadian Food Retailer with a portfolio of CBD-infused consumer packed goods (“CPGs”).
AgraFlora Organics annonce la signature d’une lettre d'intention non contraignante pour la commercialisation et la distribution de CBD et entame des discussions avec l’un des.
AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (PU31.F) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to announced the Company has commenced discussions, as well as entered into a non-binding Cannabidiol (“CBD”) Commercialization and Consulting Letter of Intent (“LOI”), dated July 31st, 2019, with one of Canada’s largest food retailers (the “Canadian Food Retailer”). The Canadian Food Retailer boasts brick and mortar stores from coast to coast, which operate under a variety of renowned retail banners. Under the terms of the non-binding LOI, AgraFlora and the Canadian Food Retailer will pursue a Supply and Consulting Agreement (the “Supply Agreement”), whereby AgraFlora will supply the Canadian Food Retailer with a portfolio of CBD-infused consumer packed goods (“CPGs”).
VANCOUVER, British Columbia, Aug. 01, 2019 -- AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth.
VANCOUVER, British Columbia, Aug. 01, 2019 -- AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth.
VANCOUVER, British Columbia, July 17, 2019 -- AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth.
VANCOUVER, British Columbia, July 17, 2019 -- Vancouver, British Columbia / July 17th, 2019 – AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA).
Comprehensive research and development (“R&D”), as well as data-driven brand-building initiatives are underway at the parent company domicile of True Focus, which in turn will benefit AgraFlora via the enhancement of its marketing toolkit as it embarks upon its go-to-market strategy for the product. Investigation and assessment of potential clinical trials by way of randomized, placebo-controlled, cross over design, pilot study to evaluate the effect of True Focus spray on healthy subjects after consuming cannabinoids. True Focus’ all natural, nutraceutical product formulations are designed to mitigate the negative side effects associated with excessive tetrahydrocannabinol (“THC”) consumption and are considered ‘patent-pending’ by way of a United States Patent and Trademark Office (“USPTO”) patent application. Delivered to the end consumer via a pocket sized, user-friendly spray bottle, True Focus’ revolutionary formulations are designed to be ingested in a sublingual manner.
Comprehensive research and development (“R&D”), as well as data-driven brand-building initiatives are underway at the parent company domicile of True Focus, which in turn will benefit AgraFlora via the enhancement of its marketing toolkit as it embarks upon its go-to-market strategy for the product. Investigation and assessment of potential clinical trials by way of randomized, placebo-controlled, cross over design, pilot study to evaluate the effect of True Focus spray on healthy subjects after consuming cannabinoids. True Focus’ all natural, nutraceutical product formulations are designed to mitigate the negative side effects associated with excessive tetrahydrocannabinol (“THC”) consumption and are considered ‘patent-pending’ by way of a United States Patent and Trademark Office (“USPTO”) patent application. Delivered to the end consumer via a pocket sized, user-friendly spray bottle, True Focus’ revolutionary formulations are designed to be ingested in a sublingual manner.
VANCOUVER, British Columbia, July 09, 2019 -- AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth.